Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katherine M. Langan"'
Victorian Specialist Immunisation Services (VicSIS) – bolstering adult clinics for COVID-19 vaccines
Autor:
Sally F. Gordon, Elise Virah Sawmy, Eleanor Duckworth, Michelle Wolthuizen, Hazel J. Clothier, Malinda Chea, Naveen Tenneti, Ngaree Blow, Jim P. Buttery, Joseph de Luca, Tony M. Korman, Sara Barnes, Charlotte Slade, Callum Maggs, Michelle L. Giles, Benjamin W. Teh, Craig Aboltins, Katherine M. Langan, Annaliese Van Diemen, Nigel W. Crawford
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
The Victorian Specialist Immunization Services (VicSIS) was established in Victoria, Australia, in February 2021, aiming to enhance vaccine safety services for Coronavirus disease (COVID-19) vaccines. VicSIS supports practitioners and patients with c
Externí odkaz:
https://doaj.org/article/3cc45d2f2e124f7ea32ce507b220a062
Autor:
Katherine M. Langan, D. Edgeworth, Jocelyn M. Choo, Tom Kotsimbos, John W Wilson, Dominic Keating, Geraint B. Rogers, Anton Y. Peleg
Publikováno v:
Journal of Cystic Fibrosis. 17:50-56
Background G551D is a class III mutation of the cystic fibrosis transmembrane regulator (CFTR) that results in impaired chloride channel function in cystic fibrosis (CF). Ivacaftor, a CFTR-potentiating agent improves sweat chloride, weight, lung func
Publikováno v:
Current opinion in infectious diseases. 28(6)
The current guidelines and recent clinical research in the management of Pseudomonas aeruginosa respiratory infections in cystic fibrosis (CF) are reviewed. Areas where further research is required will also be highlighted. P. aeruginosa is a key res
Publikováno v:
Tropical medicine and international health : TM and IH. 18(5)
It is estimated that more than 3 million healthcare workers worldwide suffer needlestick and splash injuries whilst at work resulting in the potential transmission of blood-borne pathogens via exposure to bodily fluids. Under-reporting and the subseq